Job Description: Business Overview The Rakuten Group offers over 70 services in a wide range of fields both in Japan and overseas, including internet services such as e-commerce, travel and digital content; fintech (financial) services such
Manulife is a leading international financial services provider, helping people make decisions easier and lives better. We are seeking a driven and innovative Senior Data Scientist to join our Artificial Intelligence team at Manulife Japan. As part
Job Description: Business Overview AI & Data Division (AIDD) creates powerful, customer-focused search, recommendation, data science, advertising, marketing, price, and inventory optimization solutions to a variety of businesses in commerce, fintech and mobile industries. Department Overview Mission of
Job Description: Business Overview Rakuten Group is headquartered in Japan and serves approximately 100 million domestic customers and 2 billion customers across 30 countries worldwide. We provide more than 70 services across various fields including e-commerce,
Job Description: Department Overview The President Office plays a central role in driving the Commerce & Marketing Companys management, primarily in three areas: strategy formulation, performance management, and organizational operations. This includes developing mid-term business plans,
Job Description: Overview: Rakuten group has almost 100 million customers based in Japan and 1 billion globally as well, providing more than 70 services in a variety such as e-commerce, payment services, financial services, telecommunication, media,
Job Description: Business Overview Rakuten Travel is the core service of Rakuten Group, providing a wide range of travel experiences to travelers in Japan and around the world. The service has grown to become the number
Job Description 1. Package Development & NPI Support - Support package development activities for new Power MOSFET products including: TOLL / TOLG / TOLT Bottom-side cooled (BSC) Dual-side cooled (DSC) Top-side cooled (TSC) . Advanced lead
Revolution Medicines is a late-stage clinical oncology company developing novel targeted therapies for patients with RAS-addicted cancers. The company’s R&D pipeline comprises RAS(ON) inhibitors designed to suppress diverse oncogenic variants of RAS proteins. The company’s RAS(ON)